Amankwah Ernest K, Atchison Christie M, Arlikar Shilpa, Ayala Irmel, Barrett Laurie, Branchford Brian R, Streiff Michael, Takemoto Clifford, Goldenberg Neil A
Clinical and Translational Research Organization, All Children's Research Institute, All Children's Hospital Johns Hopkins Medicine, St. Petersburg, FL, USA.
Undergraduate Medical Education, Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Thromb Res. 2014 Aug;134(2):305-9. doi: 10.1016/j.thromres.2014.05.036. Epub 2014 Jun 2.
To determine hospital-associated venous thromboembolism (HA-VTE) risk factors in critically ill neonates.
We conducted a case-control study in the neonatal intensive care unit (NICU) of All Children's Hospital Johns Hopkins Medicine (St. Petersburg, FL), from January 1, 2006 - April 10, 2013. We identified HA-VTE cases using electronic health record. Four NICU controls were randomly selected for each HA-VTE case. Associations between putative risk factors and HA-VTE were estimated using odds ratios (ORs) and ninety-five percent confidence intervals (95%CIs) from univariate and multivariate regression analyses.
Twenty-three HA-VTE cases and 92 controls were included. The annual HA-VTE incidence was approximately 1.4 HA-VTE cases per 1,000 NICU admissions. In univariate analyses, mechanical ventilation (OR=7.27, 95%CI=2.02-26.17, P=0.002), central venous catheter (CVC; OR=52.95, 95%CI=6.80-412.71, P<0.001), infection (OR=7.24, 95%CI=2.66-19.72, P<0.001), major surgery (OR=5.60, 95%CI=1.82-17.22, P=0.003) and length of stay ≥15days (OR=6.67, 95%CI=1.85-23.99, P=0.004) were associated with HA-VTE. Only CVC (OR=29.04, 95%CI=3.18-265.26, P=0.003) remained an independent risk factor in the multivariate analysis. Based on this result, the estimated risk of HA-VTE in NICU patients with a CVC was 0.9%.
This study identifies CVC as an independent risk factor for HA-VTE in critically ill neonates. However, the level of risk associated with CVC is below the conventional threshold for primary anticoagulation thromboprophylaxis. Larger studies are needed to substantiate these findings and identify novel putative risk factors to further distinguish NICU patients at highest HA-VTE risk.
确定危重新生儿医院相关性静脉血栓栓塞症(HA-VTE)的危险因素。
我们于2006年1月1日至2013年4月10日在约翰霍普金斯医学院附属儿童医院(佛罗里达州圣彼得斯堡)的新生儿重症监护病房(NICU)开展了一项病例对照研究。我们使用电子健康记录识别HA-VTE病例。每例HA-VTE病例随机选取4名NICU对照。通过单因素和多因素回归分析的比值比(OR)和95%置信区间(95%CI)评估假定危险因素与HA-VTE之间的关联。
纳入23例HA-VTE病例和92名对照。HA-VTE的年发病率约为每1000例NICU入院病例中有1.4例HA-VTE。在单因素分析中,机械通气(OR=7.27,95%CI=2.02-26.17,P=0.002)、中心静脉导管(CVC;OR=52.95,95%CI=6.80-412.71,P<0.001)、感染(OR=7.24,95%CI=2.66-19.72,P<0.001)、大手术(OR=5.60,95%CI=1.82-17.22,P=0.003)和住院时间≥15天(OR=6.67,95%CI=1.85-23.99,P=0.004)与HA-VTE相关。多因素分析中仅CVC(OR=29.04,95%CI=3.18-265.26,P=0.003)仍是独立危险因素。基于这一结果,NICU中有CVC的患者发生HA-VTE的估计风险为0.9%。
本研究确定CVC是危重新生儿HA-VTE的独立危险因素。然而,与CVC相关的风险水平低于一级抗凝血栓预防的传统阈值。需要开展更大规模的研究来证实这些发现,并识别新的假定危险因素,以进一步区分HA-VTE风险最高的NICU患者。